GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Dentsply Sirona Inc (NAS:XRAY) » Definitions » ROE %
中文

Dentsply Sirona (Dentsply Sirona) ROE %

: 8.04% (As of Dec. 2023)
View and export this data going back to 1983. Start your Free Trial

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Dentsply Sirona's annualized net income for the quarter that ended in Dec. 2023 was $268 Mil. Dentsply Sirona's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $3,334 Mil. Therefore, Dentsply Sirona's annualized ROE % for the quarter that ended in Dec. 2023 was 8.04%.

The historical rank and industry rank for Dentsply Sirona's ROE % or its related term are showing as below:

XRAY' s ROE % Range Over the Past 10 Years
Min: -21.57   Med: 1.78   Max: 13.3
Current: -3.7

During the past 13 years, Dentsply Sirona's highest ROE % was 13.30%. The lowest was -21.57%. And the median was 1.78%.

XRAY's ROE % is ranked worse than
54.13% of 811 companies
in the Medical Devices & Instruments industry
Industry Median: 0.25 vs XRAY: -3.70

Dentsply Sirona ROE % Historical Data

The historical data trend for Dentsply Sirona's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dentsply Sirona Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.01 -1.46 8.28 -21.57 -3.72

Dentsply Sirona Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.62 -2.04 9.36 -30.05 8.04

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Dentsply Sirona's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dentsply Sirona ROE % Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Dentsply Sirona's ROE % distribution charts can be found below:

* The bar in red indicates where Dentsply Sirona's ROE % falls into.



Dentsply Sirona ROE % Calculation

Dentsply Sirona's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-132/( (3811+3293)/ 2 )
=-132/3552
=-3.72 %

Dentsply Sirona's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=268/( (3375+3293)/ 2 )
=268/3334
=8.04 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Dentsply Sirona  (NAS:XRAY) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=268/3334
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(268 / 4048)*(4048 / 7285.5)*(7285.5 / 3334)
=Net Margin %*Asset Turnover*Equity Multiplier
=6.62 %*0.5556*2.1852
=ROA %*Equity Multiplier
=3.68 %*2.1852
=8.04 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=268/3334
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (268 / 228) * (228 / 252) * (252 / 4048) * (4048 / 7285.5) * (7285.5 / 3334)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.1754 * 0.9048 * 6.23 % * 0.5556 * 2.1852
=8.04 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Dentsply Sirona ROE % Related Terms

Thank you for viewing the detailed overview of Dentsply Sirona's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dentsply Sirona (Dentsply Sirona) Business Description

Traded in Other Exchanges
Address
13320 Ballantyne Corporate Place, Charlotte, NC, USA, 28277-3607
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (manufactured dental consumables and lab products) and Sirona Dental Systems (manufactured technologically-advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology and equipment through third-party distributors and the remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as Byte clear aligner).
Executives
Gregory T Lucier director C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Simon D Campion director, officer: President, CEO & Member of BOD DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Glenn Coleman officer: Executive VP & CFO C/O DENTSLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Andrea L. Frohning officer: SVP, CHRO C/O DENTSLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Jonathan Jay Mazelsky director ONE IDEXX DRIVE, WESTBROOK ME 04092
Eric Brandt director C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Staehler Cord Friedrich officer: SVP, Chief Technology Officer C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Richard C Rosenzweig officer: SVP, Corp Dev, GC & Secretary C/O DENTSPLY SIRONA INC., 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Robert Anthony Johnson officer: SVP, Chief Supply Chain Office C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Richard M Wagner officer: VP, Chief Accounting Officer 221 WEST PHILADELPHIA STREET, SUITE 60W, YORK PA 17401-2991
Barbara W. Bodem officer: Interim CFO C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Willem T Appelo officer: SVP Chief Supply Chain Officer C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Andreas G Frank officer: Executive VP, Product Group C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
John P Groetelaars director C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Cheree H Johnson officer: SVP,Chief Legal Ofcr, GC &Sec C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277

Dentsply Sirona (Dentsply Sirona) Headlines